GERARD SQUITTIERE: Open Payments
NPI 1952408395 · SMITHTOWN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$513 in 22 payments from 9 companies in 2025. Trend: 2023 $106 · 2024 $98 · 2025 $513
Food & beverage: $513
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $147 |
| La Jolla Pharmaceutical Company | 3 | $84 |
| Melinta Therapeutics, LLC | 3 | $60 |
| Gilead Sciences, Inc. | 2 | $59 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $57 |
| GENZYME CORPORATION | 1 | $36 |
| Insmed, Inc. | 1 | $30 |
| Paratek Pharmaceuticals, Inc. | 1 | $23 |
| Chiesi USA, Inc. | 1 | $17 |
Products named: ZERBAXA, Rezzayo, JARDIANCE, XACDURO, DUPIXENT, Yeztugo, Arikayce, ZEVTERA.
Industry payments across NY — which companies pay providers there.
